Eric Lefkofsky Is Solving the Cancer Information Problem
Cancer has continued its relentless march in devastating life though there is hope with more studies and more work on reducing cancer incidence. Despite research, there is still much unknown about cancer and its effects as a new study in the American Medical Association’s JAMA Oncology Journal shows.
Three cancer doctors out of Dallas studied cancer survivors who are later diagnosed with another type of cancer. The idea is that as the number of cancer survivors grows, there is scant information on the development of new cancers. Because of their cancer survivor status, these cancer survivors are not allowed to be a part of cancer trials or other cancer studies. Little is known about their particular treatment needs or possibilities.
The study found that there is a very high incidence rate of cancer among cancer survivors. As cancer is successfully treated in the future, these numbers will continue to increase. The study highlights the need to study these cancer survivors in order to see how clinical trials can benefit them and how patient outcomes can be improved. More access and availability of information needs to be provided to doctors.
Tempus is a company that is focused on enabling this type of information to be used by doctors around the country. There is a tremendous amount of information out there about cancer survivors and treatment information that isn’t making into the hands of doctors fast enough. This deficit is an opportunity and the reason why Eric Lefkofsky co-founded Tempus. He wants to make a positive difference in the lives of cancer patients.
Tempus is focused on building the world’s largest storehouse of molecular data, clinical data, and cancer information. Not only will it be a library to hold the information, but Eric Lefkofsky and his team are working on an operating system to make sense of it and provide it to doctors around the world in order to help improve cancer outcomes.
This particular study is a good example of the need for Eric Lefkofsky’s Tempus. Doctors just don’t know the effects that treatment has on those who have previously had cancer and how best to treat them. Through the tireless work of Eric Lefkovsy’s team at Tempus, this will be changing in the near future.